1. Fujii S, Ikenaka K, Fukushima M, Shirasaka T. Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 1978; 69: 763–772.
2. Kimura K, Suga K, Shimaji T, Kitamura M, Kubo K, Suzuoki Y, Isobe K. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2′-tetrahydrofuryl)-5-fluorouracil. Gastroenterologia Japonica 1980; 15: 324–329.
3. Taguchi T, Nakano Y, Jikuya K, Fujii S, Ikenaka K, Fukushima M, Shirasaka T. Effect of uracil on the antitumor activity of futraful. Gan to Kagakuryouhou (Jpn J Cancer Chemother) 1978; 5: 1161–1165. (English Abst)
4. Suga S, Yoshida Y, Tsunekawa H, Kato H, Hasegawa Y, Kimura K. Chemotherapy of gastric cancer, with special reference to morphological changes to Linits Plastica by UFTM-chemotherapy and patient survival. Iryou 1981; 35: 1081–1086. (in Japanese)
5. Garan RI, Greenberg NH, MacDonald MM, Schumacher AM, Abott BJ. Protocol for screening chemical agents and natural products against human tumors. Cancer Chemother Rep Part 3. 1972; 3: 1–103.